Portfolio of Biotech Stocks: Cancer
Here is a sample of 18 biotech stocks that provide cancer detection and treatments.
Biotech Stocks: Cancer
Price Quote & Dividend
1-Yr Price Chart
|Price and dividend data from Quandl.|
To inspect the performance of the Biotech Stocks: Cancer portfolio, see the returns table and chart below. Portfolio values are computed using monthly closes for from Quandl. The 13 included in the portfolio computations are: AMGN, ARIA, ARRY, CELG, CLDX, EXEL, IMUC, IMGN, INCY, MDVN, SCLN, SGEN and SPPI. The current value of the portfolio assumes that $769.23 was invested (total of $10,000) in each at its closing weekly price for the current date in 2008. The 5 excluded from the portfolio computations because of insufficient price data are: ECYT, JUNO, OMED, PBYI and TSRO.
Portfolio of Big Pharmaceuticals Stocks: Cancer
Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks
Portfolio of Biotech Stocks: Arthritis
Portfolio of Biotech Stocks: Diabetes
Portfolio of Biotech Stocks: Hepatitis C
Portfolio of Dividend-Paying Pharmaceutical Stocks
Portfolio of Gene Editing (CRISPR) Stocks